A groundbreaking new study has pinpointed the ideal amount of exercise needed to combat hepatic steatosis, a condition often linked with metabolic dysfunction-related liver disease (MASLD). This condition is significant because it not only accelerates the progression towards severe liver issues such as cirrhosis but also increases the risk of heart disease and certain types of cancer. The positive news is that in its early stages, hepatic steatosis can be reversed. As a result, clinical guidelines advocate for exercise as the primary treatment method for this condition, reinforcing the idea of "exercise as medicine."
In recent years, researchers have been delving into how various elements of exercise regimens affect health outcomes, particularly through what are known as "dose-specific exercise interventions." However, the existing body of evidence lacks clarity on which particular type of exercise is most effective for alleviating hepatic steatosis or how the dosage of each exercise type correlates with health improvements. This gap in knowledge means that we cannot yet confidently determine the most effective and efficient exercise dosage for treating this condition.
To fill this void, a systematic review was released online on January 12, 2026, in the Journal of Sport and Health Science by a team of researchers from China. This comprehensive study, titled "Dose-response relationship between exercise and hepatic steatosis: A systematic review with Bayesian network meta-analysis of randomized controlled trials," aims to refine our understanding of the optimal doses and types of exercise required to reduce hepatic steatosis in patients suffering from MASLD.
The research, spearheaded by Associate Professor Chunxiang Qin and featuring Dr. Xinyun Tan from the Xiangya School of Nursing as the lead author, seeks to answer three pivotal questions: (1) Which exercise type is most effective at diminishing hepatic steatosis? (2) What is the best dosage for achieving maximum effectiveness? and (3) What is the minimum dose necessary to observe a clinically significant improvement?
To compile their findings, the authors conducted thorough literature searches across twelve databases in both Chinese and English, including well-known sources like PubMed, Web of Science, and Embase. They reviewed a total of 1,892 records published since the inception of these databases until May 27, 2025, ultimately narrowing it down to 24 relevant studies for their analysis. Two researchers closely followed a strict multi-stage screening process to ensure the reliability of their results and reduce bias.
The findings reveal a complex, nonlinear relationship between the amount of exercise and the reduction of hepatic steatosis. Initially, as the volume of exercise increases, so do the benefits for the liver: surpassing a dose of 460 MET-min/week leads to the smallest clinically significant difference; however, the benefits start to level off past 630 MET-min/week, reaching optimum levels at around 850 MET-min/week. Importantly, this relationship varies by exercise type, which may be due to the unique ways each type helps decrease liver fat. Particularly, a regimen combining both aerobic and resistance training that exceeds 130 MET-min/week is adequate to yield meaningful improvements in liver health.
Dr. Qin points out that "the combination of aerobic and resistance exercises offers both therapeutic and dosage benefits for reducing hepatic steatosis," suggesting that this approach may utilize the complementary strengths of both forms of exercise to provide more extensive health advantages than either would achieve alone. Furthermore, the research supports the "Extreme Exercise Hypothesis," which posits safe thresholds for exercise dosage that can induce beneficial effects on liver health.
This study also found that the ability of exercise to lower hepatic steatosis could be influenced by individual factors such as the specific status of the disease, any medications being taken, and the duration of the exercise intervention. Therefore, it is crucial to personalize exercise prescriptions based on individual characteristics to maximize the potential benefits of exercise treatments.
In conclusion, Dr. Tan states, "Although our evidence-based synthesis elucidates the optimal exercise dose and type for tackling hepatic steatosis, further clinical trials are essential to confirm the interaction between the doses and types of exercise." Future efforts should focus on developing personalized exercise plans and refining interventions to create more precise, tailored tools that enhance individual health outcomes while highlighting the critical role of exercise in improving public health.
